ModelEdge

Eagle Pharmaceuticals, Inc.
EGRX
Filing Type8-K
Filing Date8/26/2024
Updated8/27/24, 2:30 PM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Reg. FD
EX-10.1EXHIBIT 10.1
EX-99.1Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Reg. FD
GRAPHICGraphic